Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amgen

277.05
+3.371.23%
Volume:607.31K
Turnover:167.95M
Market Cap:148.95B
PE:36.65
High:278.47
Open:275.70
Low:274.50
Close:273.68
Loading ...

Amgen Is Getting Into the Obesity Drug Business. Buy the Stock Before It Becomes the Next Winner. -- Barrons.com

Dow Jones
·
10 Apr

Biotech Stock Roundup: PCRX Up on Patent News, EWTX Down on Study Data & More

Zacks
·
10 Apr

Why drug stocks are no longer a safe haven from the stock market's turmoil

Dow Jones
·
09 Apr

Amgen, Merck Share Losses Contribute To Dow's 262-Point Drop

Dow Jones
·
09 Apr

Major Pharma Stocks Down Amid Tariff Turmoil

MT Newswires Live
·
09 Apr

Merck, Goldman Sachs Share Losses Lead Dow's 166-Point Fall

Dow Jones
·
09 Apr

Shares of Drugmakers Down After Trump Threatens Tariffs on Sector

THOMSON REUTERS
·
09 Apr

Morgan Stanley Adjusts Price Target on Amgen to $330 From $328, Keeps Equalweight Rating

MT Newswires Live
·
09 Apr

Amgen Inc Says CEO Robert a. Bradway's 2024 Total Compensation Was $24.4 Mln- SEC Filing

THOMSON REUTERS
·
09 Apr

Morgan Stanley Keeps Their Hold Rating on Amgen (AMGN)

TIPRANKS
·
09 Apr

Amgen price target raised to $330 from $328 at Morgan Stanley

TIPRANKS
·
09 Apr

BUZZ-US drugmakers fall as Trump threatens tariffs again

Reuters
·
09 Apr

Gilead Sciences Down 3%, Amgen Down 2.9%, Pfizer Down 2.7%

THOMSON REUTERS
·
09 Apr

Drugmakers Down Premarket After Trump Threatens Tariffs on Sector

THOMSON REUTERS
·
09 Apr

Apple, Nike Share Losses Lead Dow's 250-Point Fall

Dow Jones
·
09 Apr

Goldman Sachs Adjusts Amgen Price Target to $408 From $370, Maintains Buy Rating

MT Newswires Live
·
09 Apr

LLY vs. NVO: Which Weight-Loss Drug Stock is a Stronger Play Now?

Zacks
·
08 Apr

Should Schwab U.S. Dividend Equity ETF (SCHD) Be on Your Investing Radar?

Zacks
·
08 Apr

Ema: Amgen to Stop Marketing All Strengths of Mimpara Tablets in EU/Eea Markets Due to Commercial Reasons

THOMSON REUTERS
·
07 Apr

NVO & LLY Shares Down on Exclusion of Obesity Drugs From Medicare

Zacks
·
07 Apr